$ARNA News Arena shares surge as marketer doubles sales

New Post Public Reply Private Reply Replies (0) Message Board

Nov 12, 2013 at 11:14 PM

$ARNA News

Arena shares surge as marketer doubles sales force for diet drug 11:41 a.m. Oct. 15, 2013 - Russ Britt
Obesity drug makers jockey for position as analysts praise Vivus 12:06 p.m. Oct. 3, 2013 - Russ Britt
Hedge funds are buying these stocks right now 1:46 p.m. July 23, 2013 - Insider Monkey
5 stocks insiders are buying 1:52 p.m. June 7, 2013 - Insider Monkey
6 gut checks before the stock market's opening bell 6:47 a.m. March 7, 2013 - Shawn Langlois
Stocks to watch Monday: Transocean, Stratasys 9:22 a.m. March 4, 2013 - Sue Chang
Arena Pharmaceuticals down 7.4% in premarket 9:11 a.m. Jan. 22, 2013 - Steve Gelsi
What 2012’s winners and losers say about 2013 6:00 a.m. Dec. 14, 2012 - Howard Gold
6 gut checks before the stock market's opening bell 6:50 a.m. Dec. 12, 2012 - Shawn Langlois
4 charts challenging resistance 7:06 a.m. Oct. 16, 2012 - The Trading Deck
Vivus sees EU regulators rejecting diet drug 12:16 p.m. Sept. 21, 2012 - MarketWatch.com
Vivus falls 11% on EU drug approval update 11:07 a.m. Sept. 21, 2012 - Val Brickates Kennedy
Arena rises as Vivus sees anti-obesity setback 7:49 a.m. Sept. 21, 2012 - Greg Morcroft
Vivus says Europe likely to reject obesity drug 7:33 a.m. Sept. 21, 2012 - MarketWatch.com
Orexigen soars 19% on analyst buy rating 12:46 p.m. Sept. 6, 2012 - Val Brickates Kennedy
Arena jumps 12% amid takeover speculation 1:55 p.m. Aug. 14, 2012 - Val Brickates Kennedy
Arena trips Nasdaq short-sale circuit breaker 3:01 p.m. Aug. 1, 2012 - Val Brickates Kennedy
Arena Pharma share drop trips short-sale limit 2:16 p.m. Aug. 1, 2012 - Laura Mandaro
Eisai gears up for launch of Arena's diet drug 9:32 a.m. July 30, 2012 - Val Brickates Kennedy
Apple, Arena active; Lumber Liquidators at new high 9:06 a.m. July 25, 2012 - blogs.marketwatch.com

Arena Expands Marketing Of Obesity Drug To Help Shrink Waistlines 5:00 p.m. Today - TheStreet.com
10-Q: ARENA PHARMACEUTICALS INC 3:52 p.m. Today - Edgar Online - (EDG = 10Q, 10K)
Jim Cramer: Buy Apple, Sell AMD, and 2 More Stock Picks 12:05 p.m. Today - Wall St. Cheat Sheet
Arena Pharmaceuticals (ARNA) Worth a Look: Stock Surges 10.6% - Tale of the Tape 8:44 a.m. Today - Zacks.com
Cramer's Lightning Round - Don't Back Away From The Hottest Stock In The Universe (11/11/13) 6:03 a.m. Today - Seeking Alpha
'Mad Money' Lightning Round: 6:00 a.m. Today - TheStreet.com
Mid-Afternoon Market Update: Arena Pharma Gets a Boost on Jefferies Report as Markets Rise 2:54 p.m. Nov. 11, 2013 - benzinga.com
Trade-Ideas: Arena Pharmaceuticals (ARNA) Is Today's "Barbarian At The Gate" Stock 2:05 p.m. Nov. 11, 2013 - TheStreet.com
Tesla Owner Responds to Fire, Lululemon’s PR Battles Renew, and 3 More Hot Stocks 12:17 p.m. Nov. 11, 2013 - Wall St. Cheat Sheet
Arena Pharmaceuticals (ARNA) Worth Watching: Stock Surges 17.4% - Analyst Blog 9:02 a.m. Nov. 11, 2013 - Zacks.com
Is Eisai Making A Down Payment On Arena? 7:17 a.m. Nov. 11, 2013 - Seeking Alpha
Arena Pharmaceuticals' CEO Discusses Q3 2013 Results - Earnings Call Transcript 5:49 a.m. Nov. 9, 2013 - Seeking Alpha
Arena Pharma Q3 Loss Narrower than Expected - Analyst Blog 5:00 p.m. Nov. 8, 2013 - Zacks.com
U.S. Judge Orders Ex-Morgan Staney Adviser to Return Data and 2 Heavily Traded Stocks to Follow 3:59 p.m. Nov. 8, 2013 - Wall St. Cheat Sheet
VIVUS Loss In Line with Ests, Shares Fall - Analyst Blog 4:45 p.m. Nov. 7, 2013 - Zacks.com
Arena Pharmaceuticals, Eisai Expand Marketing and Supply Agreement for BELVIQ 3:03 p.m. Nov. 7, 2013 - benzinga.com
Arena's Belviq Refills - Week 20 12:43 a.m. Nov. 5, 2013 - Seeking Alpha
Arena Pharmaceuticals - Belviq OTC? 3:09 a.m. Nov. 4, 2013 - Seeking Alpha
Arena's Belviq - Week 20 Sales Data 1:28 p.m. Nov. 1, 2013 - Seeking Alpha
Arena Stock Reacts To Eisai Quarterly Call 10:26 a.m. Nov. 1, 2013 - Seeking Alpha

Biotechnology Companies' Quarterly Results - Research Report on Geron, Santarus, Merrimack, Clovis, and Arena 8:00 a.m. Today - PR Newswire
GOGO, CLDX, VPHM and ARNA Added to NASDAQ Active Stock Watch List at EPR 10:14 a.m. Nov. 11, 2013 - ACCESSWIRE
TrendingWallStreet.com Initiates Research on EGY, GLER, PGLO, and ARNA 12:16 a.m. Nov. 11, 2013 - ACCESSWIRE
Arena Pharmaceuticals Provides Corporate Update and Reports Third Quarter 2013 Financial Results 4:10 p.m. Nov. 7, 2013 - PR Newswire
Arena Pharmaceuticals and Eisai Expand Marketing and Supply Agreement for BELVIQ® (lorcaserin HCl) to Include Most Countries Worldwide 4:02 p.m. Nov. 7, 2013 - PR Newswire
FDA Approvals, Successful Product Launches, Upcoming Earnings Schedules and Quarterly Financial Results - Research Report on Pfizer, Mettler-Toledo, Arena, Wright Medical, and Ophthotech 8:00 a.m. Nov. 7, 2013 - PR Newswire
Must Watch Stock News: Arena Pharmaceuticals, Hewlett-Packard Company, Resorts International, Alpha Natural Resources, Chevron Corporation 1:56 p.m. Nov. 4, 2013 - PR Newswire
Pre-Market Review: Arena Pharma Inc., Geron Corp., Incyte Corp. Ltd, and Spectrum Pharma Inc. 9:00 a.m. Oct. 31, 2013 - PR Newswire
Arena Pharmaceuticals to Host Corporate Update and Financial Results Conference Call and Webcast on Thursday, November 7 8:00 a.m. Oct. 30, 2013 - PR Newswire
Sales Strategies, Upcoming Financial Results Schedules, Clinical Study Updates, and FDA Agreements - Research Report on Arena, Seattle Genetics, Halozyme, Insmed, and Omeros 8:00 a.m. Oct. 21, 2013 - PR Newswire
Arena Pharmaceuticals Reports That Eisai Will Double BELVIQ® (lorcaserin HCl) CIV Sales Force by December 9:03 a.m. Oct. 15, 2013 - PR Newswire
Early Briefing and Review: Arena Pharma Inc., Spectrum Pharma Inc., Incyte Corp. Ltd., and Geron Corp. 9:26 a.m. Oct. 8, 2013 - PR Newswire
Drug Approvals, Data Presentations, Conferences, Increased Funding, and Merger Agreements - Research Report on Theravance, Arena, Exelixis, Verenium, and Enanta 8:00 a.m. Sept. 25, 2013 - PR Newswire
Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference 8:00 a.m. Sept. 23, 2013 - PR Newswire
Arena Pharmaceuticals to Present Clinical Data for BELVIQ® (lorcaserin HCl) CIV at the 49th Annual Meeting of the European Association for the Study of Diabetes (EASD) 8:00 a.m. Sept. 18, 2013 - PR Newswire
Arena Pharmaceuticals Provides Update as Eisai's Launch of BELVIQ® (lorcaserin HCl) CIV Enters Consumer Phase 8:00 a.m. Sept. 16, 2013 - PR Newswire
Track Insider Trading in Facebook, Zynga, Arena Pharmaceuticals, Lululemon Athletica, Weatherford International, and Bank of America 8:55 a.m. Sept. 13, 2013 - PR Newswire
Wall Street Fundamentals Releases New In-Depth Stock Reports on ARIA, ARNA, EXEL and OREX 9:05 a.m. Sept. 11, 2013 - ACCESSWIRE
Arena Pharmaceuticals to Present at the Bank of America Merrill Lynch Global Healthcare Conference 8:00 a.m. Sept. 6, 2013 - PR Newswire
Successful Clinical Trials, Data Presentations, Promising Studies, Fulfilled Agreements and Investors Conferences - Research Report on Arena, BioMarin, Clovis Oncology, MannKind, and Medivation 8:00 a.m. Sept. 3, 2013 - PR Newswire

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

West Virginia Water Gains: Central Grove Upgrade Begins

Kickoff at Central Grove: What’s Brewing? Ever wander through Kearneysville, W.Va., and wonder what’s going on with that bustling crew near Goldenrod Drive? The folks at West Virginia American Water have kicked off groundwork for the much-anticipated Central Grove Water Treatment Plant. This, comrades, isn’t just some shiny new shed we’re talking about. Oh no,...

Clean Energy: How COP31 Can Change the Future

Global Warming: A Battle Heating Up Fast It's like trying to run uphill while carrying the baggage of outdated promises. We’ve got business bigwigs rallying at COP31, demanding the world to get serious about clean energy. If they don’t, we're looking at warming rocketing up to 2.6°C come year 2100. Who's listening though? The Call for Clean Electrification This mob,...

AZZ Inc.'s 2026 Sustainability Report: A Closer Look

Diving into AZZ's Sustainability Commitment AZZ Inc., known in the trading circles as NYSE:AZZ, has just dropped its 2026 Sustainability Report and it’s quite the document to chew on. This ain't your typical corporate fluff. Tom Ferguson, the man steering the AZZ ship, laid it down plain and simple. This report isn’t just about ticking boxes for ESG; it’s reflecting...

PPL Reports Strong Q3; Long-Term EPS Growth Up

Solid Earnings in a Challenging Market Anytime you start hearing a company like PPL boasting about their quarterly earnings, it's time to sit up straight and pay attention. The utility giant didn’t just match expectations, they beat 'em, clocking in with $0.54 per share in ongoing earnings for Q3 2026, up from $0.48 the previous year. Not a bad step forward if you ask...

AiNET Prevails in Breach of Contract Jury Verdict

AiNET's Legal Triumph Shakes Up the IT Sector Well, talk about a courtroom drama. Greenberg Traurig just snagged a big win for AiNET over in Prince George's County, Maryland, and it's a classic reminder that due diligence isn't just a nice-to-have—it's a must. AiNET found itself in the center of a breach of contract brawl with Tech Finance Co., and guess what? The jury...

Encore Boston Harbor Workers Triumph After 62-Day Strike

Labor Standoff at Encore Boston Harbor Ends After a stormy 62 days on the picket lines, around 1,300 workers at Encore Boston Harbor finally find themselves back at their posts, carrying with them the spoils of hard-fought victory. This isn't just a paper contract; it's a banner for worker solidarity. These aren't your run-of-the-mill stock flips, folks; this fight was...

Drake Software Unleashes AI to Boost Tax Prep Efficiency

Tax time's approaching, and Drake Software's rolling out some high-octane solutions to keep tax professionals from drowning in paperwork. We're talking about AI innovations integrated right into the Drake Tax suite—an evolution that could shift the gears of tax prep massively. AI Revolution in Tax Preparedness Drake Software’s got some tricks up its sleeve for Tax...

ELEGOO Gears Up for Formnext 2026 With New Innovations

A New Frontier in 3D Printing The silicon buzz surrounding ELEGOO's unveiling at Formnext 2026 is about as palpable as the smell of hot silicone on a fresh print. This Shenzhen-based company ain't sitting on past laurels. Nope, they're pushing the envelope with a bunch of spiffy new 3D devices, right from FDM printers to the all-in-one M1 Ultra scanner. Spotlight on Key...

TDS Hits Bumps but Keeps Shareholders Happy

High Hopes and Hard Hits: TDS in 2026 Listen up, folks. Telephone and Data Systems, Inc. (NYSE: TDS) just popped the hood on their third quarter earnings, and it's a mixed bag with plenty to chew over. Operating revenues are slightly down from last year, but management's got some tricks up their sleeves. CEO Walter Carlson is trumpeting their expanded fiber service...

SM Investments Wins Five Golden Arrows: Governance on Point

Gold Arrows and Golden Standards What’s in a bunch of gold arrows, you might ask? Well, for SM Investments Corporation, those Five Golden Arrows from the Institute of Corporate Directors aren't just shiny trinkets. They're badges of honor, symbols of a rock-solid governance fortress. For the third year running, they’ve nailed the top spot under the corporate...